Reduces blood pressure. Sold as Nipride, Nitropress, Sodium Nitroprusside, Nipride Rtu In Sodium Chloride 0.9%. Every FDA application for this active ingredient: 4 branded and 25 generic.
As of Nov 16, 2026, FDA lists 29 applications for Sodium Nitroprusside (sold as Nipride, Nitropress, Sodium Nitroprusside and others), first approved May 10, 1974, with 1 new use approved and 0 published complete response letters.
| Antidepressant Therapy for Improved Blood Vessel Health After PreeclampsiaPreeclampsia, Endothelial Function · Anna Stanhewicz, PhD | Early phase 1 | Recruiting | Jul 20, 2026 |
| Endothelial Dysfunction After SCISpinal Cord Injuries, Endothelial Dysfunction · Craig Hospital | — | Recruiting | Nov 13, 2025 |
| Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord InjurySpinal Cord Injuries, Endothelial Dysfunction · Craig Hospital | — | Recruiting | Nov 13, 2025 |
| The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After PregnancyGestational Diabetes Mellitus (GDM), Postpartum Women · Anna Stanhewicz, PhD | Phase 1 | Recruiting | Apr 4, 2025 |
| Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)Large Vessel Vasculitis, Giant Cell Arteritis (GCA) · University of Edinburgh | Phase 2 | Recruiting | Mar 20, 2025 |
| The FOCUS-ADHF RegistryAcute Heart Failure With Reduced Ejection Fraction, Decompensation; Heart, Congestive · ASL Città di Torino | — | Recruiting | Dec 10, 2024 |
| Early Neurovascular Adaptations in Aging WomenWomen, Sympathetic Nervous System · University of Missouri-Columbia | Early phase 1 | Recruiting | Jul 25, 2024 |
| Role of Endothelial Function in SCI CVD RiskSpinal Cord Injuries, Cardiovascular Diseases · Craig Hospital | — | Recruiting | Jun 5, 2024 |
| May 10, 1974 | NiprideNDA 17546 · New molecular entity | Roche | 7 | Discontinued |
| Sep 8, 1981 | NitropressNDA 18450 · New formulation or manufacturer | Abbvie | 7 | Discontinued |
| Jul 28, 1982 | Sodium NitroprussideNDA 18581 | Baxter Hlthcare | 10 | Discontinued |
| Jun 9, 1986 | NitropressANDA 70566 | Hospira | 15 | Discontinued |
| Nov 16, 1987 | NitropressANDA 71555 | Abbott | 3 | Discontinued |
| Aug 1, 1988 | NitropressANDA 71961 | Vpna | 5 | Discontinued |
| Mar 30, 1992 | Sodium NitroprussideANDA 73465 | Teva Parenteral | 1 | Discontinued |
| Dec 8, 2016 | Sodium NitroprussideANDA 207426 | Sagent Pharms Inc | 0 | Marketed |
| Mar 8, 2017 | Nipride Rtu In Sodium Chloride 0.9%NDA 209387 · New formulation or manufacturer | Exela Pharma | 2 | Marketed |
| May 4, 2017 | Sodium NitroprussideANDA 208635 | Epic Pharma LLC | 0 | Discontinued |
| May 25, 2017 | Sodium NitroprussideANDA 207499 | Nexus | 0 | Marketed |
| Nov 7, 2017 | Sodium NitroprussideANDA 209493 | Amneal | 0 | Marketed |
| Dec 8, 2017 | Sodium NitroprussideANDA 209352 | Micro Labs | 0 | Marketed |
| Dec 18, 2017 | Sodium NitroprussideANDA 209832 | Amphastar Pharms Inc | 0 | Discontinued |
| Apr 17, 2018 | Sodium NitroprussideANDA 210763 | Mylan Labs Ltd | 1 | Marketed |
| Jun 26, 2018 | Sodium NitroprussideANDA 209834 | Chartwell Rx | 0 | Discontinued |
| Jul 16, 2018 | Sodium NitroprussideANDA 210855 | Cipla | 0 | Discontinued |
| Aug 10, 2018 | Sodium NitroprussideANDA 209584 | Pharmobedient | 0 | Discontinued |
| Aug 17, 2018 | Sodium NitroprussideANDA 210882 | Somerset Theraps LLC | 1 | Marketed |
| Nov 26, 2018 | Sodium NitroprussideANDA 210467 | Sun Pharm | 0 | Discontinued |
| Apr 10, 2019 | Sodium NitroprussideANDA 210114 | Dr Reddys | 0 | Marketed |
| Nov 29, 2019 | Sodium NitroprussideANDA 211016 | Caplin | 0 | Marketed |
| Aug 25, 2020 | Sodium NitroprussideANDA 214199 | Hainan Poly | 0 | Marketed |
| Oct 29, 2020 | Sodium NitroprussideANDA 211277 | Xiromed | 0 | Discontinued |
| Dec 10, 2020 | Sodium NitroprussideANDA 211934 | Eugia Pharma | 0 | Discontinued |
| Jul 12, 2021 | Sodium NitroprussideANDA 214971 | Be Pharms | 0 | Marketed |
| Aug 26, 2022 | Sodium NitroprussideANDA 215846 | Hainan Poly | 0 | Marketed |
| Nov 8, 2022 | Sodium NitroprussideANDA 208923 | Avet Lifesciences | 0 | Discontinued |
| — | Sodium NitroprussideANDA 70031 | Abraxis Pharm | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA